These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 32848431)

  • 21. Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection.
    Liang Y; Wang ML; Chien CS; Yarmishyn AA; Yang YP; Lai WY; Luo YH; Lin YT; Chen YJ; Chang PC; Chiou SH
    Front Immunol; 2020; 11():1022. PubMed ID: 32574260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coronavirus Infections in Children Including COVID-19: An Overview of the Epidemiology, Clinical Features, Diagnosis, Treatment and Prevention Options in Children.
    Zimmermann P; Curtis N
    Pediatr Infect Dis J; 2020 May; 39(5):355-368. PubMed ID: 32310621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group.
    Al-Shamsi HO; Alhazzani W; Alhuraiji A; Coomes EA; Chemaly RF; Almuhanna M; Wolff RA; Ibrahim NK; Chua MLK; Hotte SJ; Meyers BM; Elfiki T; Curigliano G; Eng C; Grothey A; Xie C
    Oncologist; 2020 Jun; 25(6):e936-e945. PubMed ID: 32243668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention and treatment of COVID-19 disease by controlled modulation of innate immunity.
    Schijns V; Lavelle EC
    Eur J Immunol; 2020 Jul; 50(7):932-938. PubMed ID: 32438473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insights into the Recent 2019 Novel Coronavirus (SARS-CoV-2) in Light of Past Human Coronavirus Outbreaks.
    Ashour HM; Elkhatib WF; Rahman MM; Elshabrawy HA
    Pathogens; 2020 Mar; 9(3):. PubMed ID: 32143502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) - an update on the status.
    Abd El-Aziz TM; Stockand JD
    Infect Genet Evol; 2020 Sep; 83():104327. PubMed ID: 32320825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The 2020 Pandemic: Current SARS-CoV-2 Vaccine Development.
    Alturki SO; Alturki SO; Connors J; Cusimano G; Kutzler MA; Izmirly AM; Haddad EK
    Front Immunol; 2020; 11():1880. PubMed ID: 32973779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths.
    Lai CC; Liu YH; Wang CY; Wang YH; Hsueh SC; Yen MY; Ko WC; Hsueh PR
    J Microbiol Immunol Infect; 2020 Jun; 53(3):404-412. PubMed ID: 32173241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. From SARS to COVID-19: What lessons have we learned?
    Liu Q; Xu K; Wang X; Wang W
    J Infect Public Health; 2020 Nov; 13(11):1611-1618. PubMed ID: 32888871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overview of coronavirus disease 2019: Treatment updates and advances.
    Luo YH; Chiu HY; Weng CS; Chen YM
    J Chin Med Assoc; 2020 Sep; 83(9):805-808. PubMed ID: 32520770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coronavirus diseases and pregnancy: COVID-19,SARS, and MERS.
    Fathi M; Vakili K; Deravi N; Yaghoobpoor S; Ahsan E; Mokhtari M; Moshfeghi M; Vaezjalali M
    Przegl Epidemiol; 2020; 74(2):276-289. PubMed ID: 33112124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response.
    Astuti I; Ysrafil
    Diabetes Metab Syndr; 2020; 14(4):407-412. PubMed ID: 32335367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coronavirus Disease: A Review of a New Threat to Public Health.
    Ramphul K; Mejias SG
    Cureus; 2020 Mar; 12(3):e7276. PubMed ID: 32300496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The epidemiology and clinical information about COVID-19.
    Ge H; Wang X; Yuan X; Xiao G; Wang C; Deng T; Yuan Q; Xiao X
    Eur J Clin Microbiol Infect Dis; 2020 Jun; 39(6):1011-1019. PubMed ID: 32291542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COVID-19 Outbreak: Pathogenesis, Current Therapies, and Potentials for Future Management.
    Hossain MF; Hasana S; Mamun AA; Uddin MS; Wahed MII; Sarker S; Behl T; Ullah I; Begum Y; Bulbul IJ; Amran MS; Rahman MH; Bin-Jumah MN; Alkahtani S; Mousa SA; Aleya L; Abdel-Daim MM
    Front Pharmacol; 2020; 11():563478. PubMed ID: 33178016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies.
    Sharma A; Tiwari S; Deb MK; Marty JL
    Int J Antimicrob Agents; 2020 Aug; 56(2):106054. PubMed ID: 32534188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a newly emerged pathogen: an overview.
    Rathore JS; Ghosh C
    Pathog Dis; 2020 Aug; 78(6):. PubMed ID: 32840560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coronavirus Disease 2019: Coronaviruses and Blood Safety.
    Chang L; Yan Y; Wang L
    Transfus Med Rev; 2020 Apr; 34(2):75-80. PubMed ID: 32107119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China.
    Yang Y; Peng F; Wang R; Yange M; Guan K; Jiang T; Xu G; Sun J; Chang C
    J Autoimmun; 2020 May; 109():102434. PubMed ID: 32143990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.